Results of the NRG Oncology/RTOG 0848 adjuvant chemotherapy question: erlotinib + gemcitabine for resected cancer of the pancreatic head: A Phase II Randomized Clinical Trial

PURPOSE: NRG/RTOG 0848 was designed to determine if adjuvant radiation with fluoropyrimidine sensitization improved survival following gemcitabine-based adjuvant chemotherapy for patients with resected pancreatic head adenocarcinoma. In step 1 of this protocol, patients were randomized to adjuvant g...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Am J Clin Oncol
Κύριοι συγγραφείς: Abrams, Ross A., Winter, Kathryn A., Safran, Howard, Goodman, Karyn A., Regine, William F., Berger, Adam C., Gillin, Michael T., Philip, Philip A., Lowy, Andrew M., Wu, Abraham, DiPetrillo, Thomas A., Corn, Benjamin W., Seaward, Samantha A., Haddock, Michael G., Song, Suisui, Jiang, Yixing, Fisher, Barbara J., Katz, Alan W., Mehta, Sharmila, Willett, Christopher G., Crane, Christopher H.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2020
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7280743/
https://ncbi.nlm.nih.gov/pubmed/31985516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000633
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια